Cefmenoxime

Cefmenoxime (SCE-1365) is a new semisynthetic cephalosporin antibiotic. Cefmenoxime has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria[1][2].

Product Specifications

CAS Number

[65085-01-0]

Product Name Alternative

SCE-1365

UNSPSC

12352005

Hazard Statement

H315-H317-H319-H334-H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/cefmenoxime.html

Solubility

10 mM in DMSO

Smiles

O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O

Molecular Formula

C16H17N9O5S3

Molecular Weight

511.56

Precautions

P261-P264-P271-P272-P280-P285-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501

References & Citations

[1]Stamm JM, et, al. Antimicrobial activity of cefmenoxime (SCE-1365) . Antimicrob Agents Chemother. 1981 Mar;19 (3) :454-60.|[2]Tatara O, et, al. Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice. Antimicrob Agents Chemother. 1992 Jan;36 (1) :167-71.